What is going on with BPC-157?
If you have been following the news, the rules for BPC-157 are changing. As of September 2026, the FDA is looking closely at this compound because of safety concerns like immunogenicity (when your body has an immune response to a substance) and a lack of human safety data.
In July 2026, a special group called the Pharmacy Compounding Advisory Committee reviewed BPC-157 to see if it should be on the official list for pharmacy compounding. It was previously in a category for substances that might pose a significant safety risk, and regulators are still working on its final status.
The Semaglutide shortage update
For a while, pharmacies could make their own versions of semaglutide because there was not enough of the brand-name stuff to go around. That time has ended because the national shortage status is over.
Now, pharmacies have to follow strict rules about making copies of drugs that are already approved and available. The FDA has also noted that versions like semaglutide sodium are not the same as the approved versions, and they are not sure those are legal to use in compounding.
Other peptides on the watch list
Several other compounds are being watched closely by regulators. For many of these, the concern is safety or a lack of proof that they work in humans:
- GHRP-2 and GHRP-6: These were put in a category for substances with immunogenicity concerns.
- Melanotan II: This one has safety warnings because of serious side effects.
- LL-37: Regulators have flagged this for safety concerns as well.
- KPV: This was reviewed by a committee in July 2026 because there is very little information on how it affects humans.
Safety signals to watch for
When a drug is used by millions of people, scientists start to see patterns. For semaglutide, common issues include nausea, vomiting, and delayed stomach emptying. There are also newer, emerging reports being looked at, such as eye issues (NAION) and risks during surgery involving general anesthesia.
Next steps for you
Navigating these rules is complicated, and the human body is even more so. This is a great one to bring up with your doctor. If you need help finding a professional who understands these updates, you can find peptide-experienced physicians in our Find a Doctor directory or look for specialized care near you.
A qualified peptide doctor can help you understand what these regulatory changes mean for your specific health goals.
This content is sourced exclusively from TruthTides clinical reference data and does not constitute medical advice.
Referenced Peptides
This content was generated from TruthTides clinical reference data. It does not constitute medical advice. Always consult a qualified healthcare provider.